Norio Akuta

13.8k citations

358 papers · 9.4k indexed · 2 hit papers · h-index 50

Impact in

Hepatology top 0.05%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 319
- Hepatitis C virus research 235
- Hepatocellular Carcinoma Treatment and Prognosis 69
- Liver Disease and Transplantation 28
- Liver Diseases and Immunity 18
Epidemiology 292
- Liver Disease Diagnosis and Treatment 242
- Hepatitis B Virus Studies 178

Co-authors: Yoshiyuki Suzuki Fumitaka Suzuki Hiromitsu Kumada Masahiro Kobayashi Yasuji Arase Tetsuya Hosaka Hitomi Sezaki Satoshi Saitoh
Journals: Journal of Medical Virology (56 papers)Hepatology Research (52 papers)Journal of Gastroenterology (40 papers)Oncology (16 papers)Journal of Hepatology (11 papers)
Partner nations: Japan Italy United States

In The Last Decade

Norio Akuta

351 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020 2021 · 179 citations

Peers

Countries citing papers authored by Norio Akuta

Since Specialization

Citations

This map shows the geographic impact of Norio Akuta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norio Akuta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norio Akuta more than expected).

Fields of papers citing papers by Norio Akuta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norio Akuta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norio Akuta. The network helps show where Norio Akuta may publish in the future.

Co-authors

The 25 scholars most cited alongside Norio Akuta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norio Akuta Line = papers co-authored together Norio Akuta links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report Hepatology Research ·Yusuke Kawamura, Norio Akuta, (unknown), Masaru Matsumura, S. Okubo, Licht Tominaga, Shigeki Yamamoto, Yasuka Eriksson, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	2025	0
2	Efficacy of Lenvatinib and Atezolizumab Bevacizumab Combination Therapy in Patients With Combined Hepatocellular-cholangiocarcinoma Anticancer Research ·Norikazu Tanabe, Issei Saeki, Kenji Yamaoka, Tomokazu Kawaoka, Tetsu Tomonari, Joji Tani, Takeshi Terashima, Y. Kawamura, Shiro Oka, Tetsuji Takayama, Hideki Kobara, Taro Yamashita, Norio Akuta, Takahiro Yamasaki, Taro Takami	2025	1
3	Clinical Impact and Significant Technical Points of Transarterial Chemoembolization (TACE) Using the Smaller Drug-Eluting Bead M1 (DC Bead M1™) for Hepatocellular Carcinoma: A Case Series Cureus ·Yusuke Kawamura, Norio Akuta, Shigeki Yamamoto, Yasuka Eriksson, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada	2024	1
4	Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy Hepatology Research ·Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shigeki Yamamoto, Yasuka Eriksson, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, K Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	2024	2
5	Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearance Journal of Gastroenterology ·Fumitaka Suzuki, Tetsuya Hosaka, Yoshiyuki Suzuki, Hitomi Sezaki, Norio Akuta, Shunichiro Fujiyama, Yusuke Kawamura, Satoshi Saitoh, Yasuji Arase, Mariko Kobayashi, Hiromitsu Kumada	2023	2
6	Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma Clinical Journal of Gastroenterology ·Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Licht Tominaga, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Takuyo Kozuka, Hiromitsu Kumada	2022	5
7	A case of drug-induced acute liver failure caused by corticosteroids Clinical Journal of Gastroenterology ·Akira Kajiwara, Yusuke Kawamura, Keiichi Kinowaki, Nozomu Muraishi, Soichi Iritani, Norio Akuta, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Satoshi Saitoh, Masahiro Kobayashi, Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada	2022	3
8	Advantage of liver stiffness measurement before and after direct‐acting antiviral therapy to predict hepatocellular carcinoma and exacerbation of esophageal varices in chronic hepatitis C Hepatology Research ·Nobuhiko Ogasawara, Satoshi Saitoh, Norio Akuta, Hitomi Sezaki, Fumitaka Suzuki, Shunichiro Fujiyama, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2019	12
9	Long‐term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus‐related liver cirrhosis after interferon‐based therapy Hepatology Research ·Nobuhiko Ogasawara, Satoshi Saitoh, Norio Akuta, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2019	11
10	Serial changes in liver stiffness and controlled attenuation parameter following direct‐acting antiviral therapy against hepatitis C virus genotype 1b Journal of Medical Virology ·Nobuhiko Ogasawara, Masahiro Kobayashi, Norio Akuta, Yoko Kominami, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Fumitaka Suzuki, Satoshi Saitoh, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Mariko Kobayashi, Hiromitsu Kumada	2017	55
11	Correlation of Histopathological Features andGenetic Variations with Prognosis of JapanesePatients with Nonalcoholic Fatty Liver Disease Norio Akuta, Yusuke Kawamura, Fumitaka Suzuki, Satoshi Saitoh, Yasuji Arase, Hideo Kunimoto, Yushi Sorin, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Mariko Kobayashi, Kenji Ikeda, Hiromitsu Kumada	2016	1
12	Prevalence and predictive factors of diabetes in hepatitis virus positive liver cirrhosis with fasting plasma glucose level of <126 mg/dL Hepatology Research ·Naoki Matsumoto, Yasuji Arase, Yuya Seko, Norihiro Imai, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Mariko Kobayashi, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saito, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada, Kaoru Aida, Tetsuro Kobayashi	2012	7
13	[Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and chronic renal failure]. PubMed ·Norihiro Imai, Kenji Ikeda, Yuya Seko, Naoki Matsumoto, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada	2011	2
14	1330 IL28B GENOTYPE MAJOR AND RELAPSE OF PREVIOUS PEG-IFN/RBV THERAPY ARE THE CONVINCING PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN TELAPREVIR WITH PEG-IFN/RBV THERAPY Journal of Hepatology ·Yoshiyasu Karino, Itaru Ozeki, Jouji Toyota, Michio Imamura, Masataka Tsuge, Kazuaki Chayama, Hitoshi Sezaki, Norio Akuta, H Kumada	2011	2
15	IL28B But Not ITPA Polymorphism Is Predictive of Response to Pegylated Interferon, Ribavirin, and Telaprevir Triple Therapy in Patients With Genotype 1 Hepatitis C The Journal of Infectious Diseases ·Kazuaki Chayama, C. Nelson Hayes, Hiromi Abe, Daiki Miki, Hidenori Ochi, Yoshiyasu Karino, Joji Toyota, Yusuke Nakamura, Naoyuki Kamatani, Hitomi Sezaki, Mariko Kobayashi, Norio Akuta, Fumitaka Suzuki, Hiromitsu Kumada	2011	96
16	Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis Kanzo ·Norihiro Imai, Kenji Ikeda, Yuya Seko, Miharu Hirakawa, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Hiromitsu Kumada	2010	1
17	Influence of HMG-CoA reductase inhibitor to virological response of peginterferon/ribavirin combination therapy in chronic hepatitis C Kanzo ·Hitomi Sezaki, Fumitaka Suzuki, Norio Akuta, Yusuke Kawamura, Hiromi Yatsuji, Tetsuya Hosaka, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada	2008	3
18	Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test Kanzo ·Mariko Kobayshi, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Tetsuya Hosaka, Hitomi Sezaki, Hiromi Yatsuji, Yusuke Kawamura, Masahiro Kobayashi, Kenji Ikeda, Yasuji Arase, Satomi Iwasaki, Rie Mineta, Sachiyo Watahiki, Hiromitsu Kumada	2007	0
19	Response to long‐term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C Journal of Medical Virology ·Mariko Kobayashi, Fumitaka Suzuki, Norio Akuta, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Tetsuya Hosaka, Hitomi Sezaki, Masahiro Kobayashi, Satomi Iwasaki, Junko Sato, Sachiyo Watahiki, Yuzo Miyakawa, Hiromitsu Kumada	2006	25
20	Wild‐type precore and core promoter sequences in patients with acute self‐limited or chronic hepatitis B Scandinavian Journal of Gastroenterology ·Masahiro Kobayashi, (unknown), Y Arase, Kenji Ikeda, Akihito Tsubota, Yoshiyuki Suzuki, Satoshi Saitoh, (unknown), (unknown), Fumitaka Suzuki, Norio Akuta, Tetsuya Hosaka, Takashi Someya, Masamichi Matsuda, J. Sato, Y. Miyakawa, H. Kumada	2004	8

About Norio Akuta

Norio Akuta is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Rheumatology and Oncology, having authored 358 papers that have together received 9.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (242 papers), Hepatitis C virus research (235 papers), Hepatitis B Virus Studies (178 papers), Hepatocellular Carcinoma Treatment and Prognosis (69 papers), HIV/AIDS drug development and treatment (35 papers), Liver Disease and Transplantation (28 papers), Systemic Lupus Erythematosus Research (25 papers) and Liver Diseases and Immunity (18 papers). The work is most often cited by research in Hepatology (8.0k citations), Epidemiology (7.8k citations), Rheumatology (622 citations), Infectious Diseases (752 citations) and Endocrinology, Diabetes and Metabolism (599 citations). Norio Akuta has collaborated with scholars based in Japan, Italy and United States. Frequent co-authors include Yoshiyuki Suzuki, Fumitaka Suzuki, Hiromitsu Kumada, Masahiro Kobayashi, Yasuji Arase, Tetsuya Hosaka, Hitomi Sezaki, Satoshi Saitoh, Yusuke Kawamura and Mariko Kobayashi. Their work appears in journals such as Journal of Medical Virology, Hepatology Research, Journal of Gastroenterology, Oncology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact